WENDY FULLER: Open Payments
NPI 1700840568 · SOCIAL CIRCLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$863 in 43 payments from 18 companies in 2025. Trend: 2023 $704 · 2024 $891 · 2025 $863
Food & beverage: $863
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $112 |
| Lilly USA, LLC | 6 | $98 |
| AstraZeneca Pharmaceuticals LP | 5 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $85 |
| Phathom Pharmaceuticals, Inc. | 1 | $62 |
| PFIZER INC. | 3 | $61 |
| SANOFI-AVENTIS U.S. LLC | 3 | $61 |
| Esperion Therapeutics, Inc. | 2 | $49 |
| Boston Scientific Corporation | 1 | $38 |
| Abbott Laboratories | 2 | $33 |
Products named: JARDIANCE, MOUNJARO, VOQUEZNA, ELIQUIS, TZIELD, AIRSUPRA, Rybelsus, NEXLETOL.
Industry payments across GA — which companies pay providers there.
